Matthew Pauls - 10 Dec 2025 Form 4 Insider Report for Pelthos Therapeutics Inc. (CHRO)

Role
Director
Signature
/s/ Matthew Pauls
Issuer symbol
CHRO
Transactions as of
10 Dec 2025
Net transactions value
$0
Form type
4
Filing time
12 Dec 2025, 17:01:02 UTC
Previous filing
11 Dec 2025
Next filing
16 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pauls Matthew Director C/O PELTHOS THERAPEUTICS INC., 4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM /s/ Matthew Pauls 12 Dec 2025 0001573429

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTHS Common Stock Options Exercise $0 +8,493 $0.000000 8,493 02 Jul 2025 Direct F1
transaction PTHS Common Stock Options Exercise $0 +2,123 +25% $0.000000 10,616 02 Oct 2025 Direct F1
transaction PTHS Common Stock Gift $0 -9,542 -90% $0.000000 1,074 10 Dec 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTHS Restricted Stock Units Options Exercise $0 -8,493 -33% $0.000000 16,985 02 Jul 2025 Common Stock 8,493 Direct F1, F3
transaction PTHS Restricted Stock Units Options Exercise $0 -2,123 -12% $0.000000 14,862 02 Oct 2025 Common Stock 2,123 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As previously reported on a Form 4 filed July 7, 2025, on July 2, 2025, the Reporting Person was granted 25,478 restricted stock units ("RSUs"), with the initial one third (1/3) of such shares vesting on July 2, 2025, and the remainder vesting in equal installments on a quarterly basis thereafter over a period of two (2) years.
F2 On December 10, 2025, the Reporting Person transferred 9,542 shares of Common Stock to GP 2024 Trust, U/A Dated, 12/20/2024, for no consideration. The Reporting Person is not a trustee and does not retain investment or voting control over the shares. Following the gift, the Reporting Person disclaims beneficial ownership of the shares held by the Trust and reports beneficial ownership herein only to the extent of any pecuniary interest, if any.
F3 Each RSU represents a contingent right to receive one share of issuer's Common Stock.